A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia
Clinical trial NCT02148133 · COMPLETED
Trial details
- NCT number
- NCT02148133
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-23
- Primary completion
- 2015-09-10
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.